Subclinical deterioration of left ventricular function in patients with juvenile-onset systemic lupus erythematosus

被引:13
|
作者
Chung, H-T [1 ]
Huang, Y-L [2 ,3 ]
Yeh, K-W [4 ]
Huang, J-L [3 ,4 ]
机构
[1] Chang Gung Mem Hosp Linkou, Dept Pediat, Div Cardiol, Taoyuan, Taiwan
[2] Chang Gung Mem Hosp Keelung, Dept Pediat, Keelung, Taiwan
[3] Chang Gung Univ, Grad Inst Clin Med Sci, Taoyuan, Taiwan
[4] Chang Gung Mem Hosp Linkou, Dept Pediat, Div Asthma Allergy & Rheumatol, Taoyuan, Taiwan
关键词
Ventricular function; systemic lupus erythematosus; pediatric rheumatology; cardiovascular disease; DIASTOLIC FUNCTION; DISEASE-ACTIVITY; CARDIAC ABNORMALITIES; INVOLVEMENT; DYSFUNCTION; CHILDREN; ECHOCARDIOGRAPHY; RECOMMENDATIONS; CARDIOMYOPATHY; ADOLESCENTS;
D O I
10.1177/0961203314554249
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objectives: Patients with systemic lupus erythematosus (SLE) have a higher risk of myocardial involvement, which can result in ventricular dysfunction. Little is known about the chronic influence of SLE on heart function in children and adolescents. This is the first study to demonstrate long-term changes in left ventricular function in patients with juvenile-onset SLE. Methods: This was a longitudinal study of 92 patients with juvenile-onset SLE. Two-dimensional echocardiography was performed by a single pediatric cardiologist at baseline, with follow-up at six-month intervals. Clinical and laboratory parameters, disease activity, treatment, nailfold capillaroscopy, and the traditional risk factors for atherosclerosis were evaluated. The baseline comparison of ventricular function was performed against 50 age-matched controls, and the follow-up results were analyzed using generalized estimating equations. Results: The patients' mean age at baseline was 15.9 +/- 4.3 years, the mean disease duration was 3.6 +/- 3.2 years, and the mean follow-up duration was 4.5 +/- 1.6 years. At baseline, the mean left ventricular ejection fraction (LVEF) was 74.7 +/- 5.6% and the mean E/A ratio of left ventricular diastolic filling was 1.7 +/- 0.3 (E: the peak velocity at rapid left ventricular filling; A: the peak velocity during left atrial contraction). The LVEF of the SLE patients was similar to the healthy controls and it did not change during the follow-up period. In contrast, the E/A ratio was lower in the SLE patients than in the healthy controls (1.7 +/- 0.3 versus 1.88 +/- 0.37; p=0.002), and it decreased significantly with time (B +/- SE, -0.013 +/- 0.006, p=0.023). In multiple analyses, abnormal microvasculature in nailfold capillaroscopy had a negative effect on LVEF progression (p=0.039). Disease duration of SLE and proteinuria were risk factors associated with the descent of E/A ratio (p=0.014 and p=0.015, respectively). Conclusion: In patients with juvenile-onset SLE who were free of cardiac symptoms, there was evidence of declining ventricular diastolic function with time. Abnormal nailfold microvasculature, proteinuria and longer disease duration were the main risk factors for worsening of ventricular function.
引用
收藏
页码:263 / 272
页数:10
相关论文
共 50 条
  • [21] Pulmonary involvement in juvenile-onset systemic lupus erythematosus patients asymptomatic for respiratory disease
    Hala M. Lotfy
    Eman F. Halawa
    Mohamed El Baz
    Egyptian Journal of Bronchology, 2015, 9 (1) : 59 - 63
  • [22] From Childhood to Adulthood: The Trajectory of Damage in Patients With Juvenile-Onset Systemic Lupus Erythematosus
    Lim, Lily S. H.
    Pullenayegum, Eleanor
    Lim, Lillian
    Gladman, Dafna
    Feldman, Brian
    Silverman, Earl
    ARTHRITIS CARE & RESEARCH, 2017, 69 (11) : 1627 - 1635
  • [23] A systematic review of pharmacological therapies and their effectiveness on health-related quality of life outcomes in patients with juvenile-onset systemic lupus erythematosus
    Cintron, D.
    Alanis, J. M.
    Alvarez-Villalobos, N.
    Rodriguez-Gutierrez, R.
    Vila, L. M.
    LUPUS, 2020, 29 (03) : 303 - 310
  • [24] Neuropsychiatric involvement in juvenile-onset systemic lupus erythematosus: A multicenter study
    Kisaarslan, Aysenur Pac
    Cicek, Sumeyra Ozdemir
    Batu, Ezgi D.
    Sahin, Sezgin
    Gurgoze, Metin K.
    Cetinkaya, Sibel Balci
    Ekinci, Miray Kisla
    Atmis, Bahriye
    Barut, Kenan
    Adrovic, Amra
    Agar, Buket Esen
    Sahin, Nihal
    Demir, Ferhat
    Baglan, Esra
    Kara, Mehtap Akbalik
    Selcuk, Senay Zirhli
    Ozdel, Semanur
    Comak, Elif
    Akkoyunlu, Betul
    Yener, Gulcin Otar
    Yildirim, Deniz Gezgin
    Ozturk, Kubra
    Yildiz, Mehmet
    Haslak, Fatih
    Sener, Seher
    Kisaoglu, Hakan
    Baba, Ozge
    Kizildag, Zehra
    Isguder, Rana
    Caglayan, Sengul
    Bilgin, Raziye B. Guven
    Aytac, Guelcin
    Yucel, Burcu Bozkaya
    Tanatar, Ayse
    Sonmez, Hafize E.
    Cakan, Mustafa
    Kara, Aslihan
    Elmas, Ahmet T.
    Kilic, Beltinge Demircioglu
    Ayaz, Nuray Aktay
    Kasap, Belde
    Acar, Banu Celikel
    Ozkaya, Ozan
    Yuksel, Selcuk
    Bakkaloglu, Sevcan
    Aydog, Ozlem
    Aksu, Guzide
    Akman, Sema
    Donmez, Osman
    Bulbul, Mehmet
    JOINT BONE SPINE, 2023, 90 (04)
  • [26] Juvenile-onset multifocal osteonecrosis in systemic lupus erythematosus A case report
    Jin, Wenyuan
    Yang, Xinghui
    Lu, Meiping
    MEDICINE, 2021, 100 (02) : E24031
  • [27] Neuropsychiatric involvement in juvenile-onset systemic lupus erythematosus (jS']jSLE)
    Natoli, Valentina
    Charras, Amandine
    Hahn, Gabriele
    Hedrich, Christian M.
    MOLECULAR AND CELLULAR PEDIATRICS, 2023, 10 (01)
  • [28] Oral lesions in adult- and juvenile-onset systemic lupus erythematosus patients: A case series report
    Hartanto, Firstine Kelsi
    Sufiawati, Irna
    DENTAL AND MEDICAL PROBLEMS, 2024, 61 (01) : 145 - 152
  • [29] Juvenile-onset systemic lupus erythematosus: Update on clinical presentation, pathophysiology and treatment options
    Smith, Eve Mary Dorothy
    Lythgoe, Hanna
    Midgley, Angela
    Beresford, Michael William
    Hedrich, Christian Michael
    CLINICAL IMMUNOLOGY, 2019, 209
  • [30] Subclinical pulmonary abnormalities in childhood-onset systemic lupus erythematosus patients
    Veiga, C. S.
    Coutinho, D. S.
    Nakaie, C. M. A.
    Campos, L. M. A.
    Suzuki, L.
    Cunha, M. T.
    Leone, C.
    Silva, C. A.
    Rodrigues, J. C.
    LUPUS, 2016, 25 (06) : 645 - 651